bioRxiv / medRxiv
open access
CC BY 4.0
Relational Graph Convolutional Networks for Glioblastoma Biomarker Discovery via ceRNA and Copy Number Variation Analysis
Glioblastoma (GBM) is a highly aggressive brain tumor with a five-year survival rate of 6.9%, attributable in substantial part to the shortage of reliable biomarkers. Competing endogenous RNA (ceRNA) and copy number variation (CNV) analyses each carry biomarker-identification potential, but existing
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI.#247610
- GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation#1250684
- TF-DWGNet: a directed weighted graph neural network with tensor fusion for multi-omics cancer subtype classification.#244297
- Contrastive multimodal deep learning for survival prediction in grade 2/3 gliomas.#227800
- LHW-Net: An ensemble-based machine learning framework for brain tumor classification.#122721
Record · ID 1181763
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive